Manufacturing

Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash. Takeda president and CEO Christophe Weber said: “We are very pleased to…
Read More...

MilliporeSigma announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component…
Read More...

Swiss company Genticel and Genkyotex have signed an agreement to enter into strategic combination. A portfolio of NADPH oxidase (NOX) oral small molecule inhibitors are being…
Read More...

Novo Nordisk has awarded Fluor an engineering, procurement, construction and construction management contract for its new $2bn diabetes Active Pharmaceutical Ingredient (API)…
Read More...

A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in…
Read More...

GSK is opening a new global vaccines research and development (R&D) center in Rockville, Maryland, US. Up to 200 new jobs will be created at the Rockville facility, with GSK…
Read More...

US drug developer Alexion Pharmaceuticals has named David Brennan as interim CEO, effective immediately. Brennan is the former Chief Executive Officer and Executive Director of…
Read More...

West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland. The expansion is in response to…
Read More...

Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence,…
Read More...

Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine. The collaboration follows the recent acquisition of the technology for the…
Read More...

Sun Pharma has agreed to acquire 85.1% stake in JSC Biosintez, a Russian pharmaceutical firm engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.…
Read More...

Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a…
Read More...

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...

Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions. The…
Read More...

The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously…
Read More...

Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and…
Read More...

VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel. The site will house VBL's local biological drugs manufacturing facility,…
Read More...

Pilgrim Quality Solutions announced the validated release of Smart Solve Out Of Specification Management (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of…
Read More...